In addition, 77% of the experts reported performing real-time quantitative polymerase chain reaction (RQ-PCR) for BCR-ABL as a baseline at the time of diagnosis, while mutation analysis was not reported to be routinely performed at the time of diagnosis of CML in their practice (Figure 1). This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.